ReviewCancers2024

Chimeric Antigen Receptor (CAR) T-Cell Therapy in Hematologic Malignancies: Clinical Implications and Limitations.

Philipp Blüm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.